Major depression is one of the most common mental health conditions in the world. In the United States alone, about one in five adults will experience it at some point in their lives.
For many people, treatment such as medication or therapy can reduce symptoms and help them return to daily life. However, a significant number of patients do not improve even after trying many different treatments.
This condition is known as treatment-resistant depression, and it can last for years or even decades, severely affecting a person’s ability to work, maintain relationships, or enjoy life.
A new study has found that a small implanted device may offer long-lasting relief for people with the most severe forms of depression. The research was led by scientists at Washington University School of Medicine in St. Louis as part of a large clinical trial conducted across many medical centers in the United States.
The findings suggest that stimulating a major nerve in the body called the vagus nerve can significantly reduce depressive symptoms and improve quality of life for some patients who had previously run out of options.
The vagus nerve is one of the longest nerves in the body. It connects the brain to many organs, including the heart, lungs, and digestive system.
It also plays an important role in mood regulation and stress responses. Doctors have used vagus nerve stimulation for years to treat epilepsy, but researchers have been exploring whether it could also help depression.
The therapy involves surgically placing a small device under the skin in the chest. Thin wires connect the device to the vagus nerve in the neck. The device sends gentle electrical signals to the nerve at regular intervals. These signals travel to the brain and appear to affect areas involved in mood and emotional processing.
The clinical trial, known as the RECOVER study, enrolled nearly 500 people with severe treatment-resistant depression at 84 sites across the country. Most participants had struggled with depression for decades and had tried many treatments that did not work.
On average, each patient had already tried 13 different therapies, including medications, psychotherapy, and even more intensive treatments such as electroconvulsive therapy.
Researchers followed the patients for two years. Many participants showed meaningful improvement after one year of treatment, and most of those improvements continued into the second year. Patients reported fewer depressive symptoms, better ability to function in daily life, and improved overall well-being.
The results were especially encouraging because treatment-resistant depression is often difficult to treat long term. Many therapies provide short-term relief but lose effectiveness over time.
In this study, more than four out of five patients who improved during the first year maintained or increased their improvement after two years. Some patients who did not respond at first began to improve later, suggesting the therapy may take time to work.
Perhaps the most striking finding was that about one in five patients achieved remission after two years. This means their symptoms improved so much that they could function normally again. For people who had been severely depressed for decades, this level of recovery is remarkable.
Researchers also noted that even partial improvement can be life-changing for someone with severe depression. When symptoms ease, patients may regain the ability to work, care for themselves, and reconnect with loved ones. The therapy may not cure depression, but it can help people reclaim parts of their lives that were lost to the illness.
In reviewing the study findings, the results are promising but should be interpreted with caution. The treatment requires surgery and ongoing monitoring, and it may not work for everyone.
It is also expensive, which limits access for many patients. Further research is needed to determine who is most likely to benefit and how to make the therapy more widely available. Because the study focused on very severe cases, the results may not apply to people with milder forms of depression.
Even so, the research offers new hope for patients who have exhausted other treatments. It highlights the importance of exploring innovative approaches that target the brain and body in new ways. As scientists continue to study how nerve stimulation affects mood, this therapy could become a valuable option for people living with chronic, disabling depression.
If you care about mental health, please read studies about how dairy foods may influence depression risk, and 6 foods you can eat to improve mental health.
For more mental health information, please see recent studies about top foods to tame your stress, and Omega-3 fats may help reduce depression.
The study is published in the Journal of Affective Disorders.
Copyright © 2026 Knowridge Science Report. All rights reserved.
